Further, the number of cases and lack of detailed clinical information does not allow for robust biological conclusions on the effect of age, menopause status, stage, tumor grade, and race/ethnicity to adequately assess the association of AnxA1 and AnxA2 with the disparity of TNBC in pre-menopausal and women of African descent [15]. This evidence concerns the gene ANXA2 and neoplasm.